Minimal manifestation status and prednisone withdrawal in the MGTX trial

OBJECTIVE: To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG). METHODS: This study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Lee, Ikjae, Kuo, Hui-Chien, Aban, Inmaculada B., Cutter, Gary R., McPherson, Tarrant, Kaminski, Henry J., Sussman, Jon, Ströbel, Philipp, Oger, Joel, Cea, Gabriel, Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R.F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Marcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Minisman, Greg, Sonett, Joshua R., Wolfe, Gil I.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455358/
https://ncbi.nlm.nih.gov/pubmed/32611638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados